Monash University

Data updated July 16, 2026

Australia

1 Trial1 Event

The Clinical Psychedelic Lab, led by Dr. Paul Liknaitzky, conducts robust clinical trials exploring the efficacy and safety of psychedelic-assisted therapies for various mental health conditions within the Australian healthcare context.

ProfessionalOnlineMid costAcademic programmeContinuing educationPsychedelic-assisted therapy trainingAspiring practitionersLicensed cliniciansResearchers

Blossom’s read

Monash University sits near the serious, research-led end of the field rather than the commercial training end. Its Clinical Psychedelic Lab, led by Dr Paul Liknaitzky, has built a reputation in Australia for rigorous trials, therapist training, and a deliberately cautious, evidence-based approach to psychedelic-assisted therapy. It is best suited to clinicians, researchers, and health professionals who want university-backed grounding in the science and clinical considerations before any advanced practice pathway.

Who is Monash University for?

Best for health professionals, postgraduate learners, and researchers who want an academic grounding in psychedelic science or psychedelic-assisted therapy. It also suits experienced clinicians seeking evidence-based upskilling rather than experiential or retreat-style training.

What do you need before you start?

The foundation courses do not require prior knowledge. Monash states that the psychedelics education offerings are open to students from across the world, and that the courses are designed for both newcomers and experienced professionals. The site also notes that the short courses alone do not constitute sufficient training to work as a psychedelic therapist.

Is Monash University accredited?

Monash describes the programme as university-accredited and says the introductory courses may provide credit or microcredentialing towards a planned Graduate Certificate in Psychedelic Therapies, subject to formal approval and eligibility. It also says the education stream is being developed by the Clinical Psychedelic Lab within the Department of Psychiatry.

How much does it cost?

Monash does not publish a single programme price on the main education pages reviewed. The courses are framed as postgraduate short courses with flexible online delivery, 12-week duration, and live plus asynchronous learning, but tuition and inclusions are not set out on the overview pages.

What do you walk away with?

Learners gain an evidence-based understanding of psychedelic science or psychedelic-assisted therapy, including history, indigenous context, psychopharmacology, clinical research, ethics, safety, screening, therapist competencies, and current debates. The courses are also positioned as stepping stones towards future postgraduate study and, potentially, a planned Graduate Certificate in Psychedelic Therapies.

Academic Research

0 papers

Published Papers

Trial Involvement

Distinct Focus Topics

Latest Publication

Unknown

Government funding received

1 grant

MRFF — Psilocybin-assisted psychotherapy for treatment-resistant depression

2022–2027

Medical Research Future Fund (MRFF)A$2,700,000

Psilocybin Treatment-Resistant Depression (TRD)

Part of the A$14.8M MRFF clinical-trials package announced January 2022. Monash-led team evaluates the efficacy of psilocybin-assisted psychotherapy in treatment-resistant depression. PIs from the Monash Clinical Psychedelic Lab.

Source